Healthtech Startup 4baseCare & Owkin Join Hands to Advance AI-Driven Inclusive Cancer Research

The initiative seeks to transform fragmented cancer data into AI-ready insights aimed at addressing the underrepresentation of Asian and Middle Eastern Population cancer care and drug development.

Bengaluru-based startup 4baseCare, a precision oncology startup building population-relevant clinico-genomic intelligence, has partnered with France-based Owkin, an agentic AI company focused on Biological Artificial Superintelligence (BASI), to advance inclusive cancer research.

Under the agreement, both organisations will work together to transform fragmented cancer data into AI-ready insights aimed at addressing the underrepresentation of the Asian and Middle Eastern Population cancer care and drug development.

By building more representative datasets, the collaboration seeks to support more inclusive research that reflects global patient diversity, build more robust therapeutics, and drive more AI-enabled equitable standards of cancer care worldwide.

Under the partnership, OmicsBank will provide access to large-scale, multimodal clinical and multi-omics datasets sourced from historically underrepresented regions, which is expected to strengthen the foundation for more globally representative and inclusive cancer research.

Highlighting the significance of the partnership, Thomas Clozel, CEO and Co-Founder, Owkin, said, “We are on a mission to build biological artificial superintelligence to cure all diseases. Global patient data is the key to unlocking this. We are excited to enhance our collaborations in India to turn fragmented datasets into meaningful discoveries for more inclusive therapeutic breakthroughs.”

Further, by leveraging its expertise in genomic and clinical data to guide precision treatment decisions, 4baseCare will contribute its capabilities in developing inclusive genomic datasets to the partnership.

Its TarGT Indiegene test, along with other precision oncology solutions, is designed to generate deeper molecular insights into a patient’s disease, enabling more targeted and personalized treatment strategies.

Commenting on the partnership, Kshitij Rishi, COO & Co-Founder, 4baseCare, said, “Precision oncology is only as strong as the data behind it. At 4baseCare, we build inclusive genomic datasets reflecting the diversity of the global south, non Caucasian patients, and combine them with advanced AI to enable more informed treatment decisions. We look forward to working with Owkin to ensure underrepresented populations are meaningfully included in global research and next-generation drug development.”

Recently, the startup had also partnered with Caritas Hospital of Kottayam, aimed at advancing personalized cancer care in Kottayam and nearby regions of Kerala.

Stay tuned for more such updates on Digital Health News